Claire Gallois

1.1k total citations
47 papers, 540 citations indexed

About

Claire Gallois is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Claire Gallois has authored 47 papers receiving a total of 540 indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Oncology, 19 papers in Pathology and Forensic Medicine and 16 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Claire Gallois's work include Colorectal Cancer Treatments and Studies (28 papers), Genetic factors in colorectal cancer (19 papers) and Gastric Cancer Management and Outcomes (10 papers). Claire Gallois is often cited by papers focused on Colorectal Cancer Treatments and Studies (28 papers), Genetic factors in colorectal cancer (19 papers) and Gastric Cancer Management and Outcomes (10 papers). Claire Gallois collaborates with scholars based in France, Italy and Spain. Claire Gallois's co-authors include Julien Taı̈eb, Aziz Zaanan, Pierre Laurent‐Puig, Simon Pernot, Édouard Auclin, Déwi Vernerey, Richard Douard, Franck Bonnetain, Thierry Lecomte and Astrid Lièvre and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Claire Gallois

44 papers receiving 537 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Claire Gallois France	12	368	172	126	122	100	47	540
Maria Banzi Italy	14	382 1.0×	102 0.6×	161 1.3×	117 1.0×	69 0.7×	49	500
Guanghai Dai China	15	281 0.8×	57 0.3×	121 1.0×	265 2.2×	75 0.8×	61	663
N. Saoudi Gonzalez Spain	12	310 0.8×	139 0.8×	100 0.8×	130 1.1×	48 0.5×	51	447
Kari Trumpi Netherlands	9	222 0.6×	111 0.6×	44 0.3×	257 2.1×	41 0.4×	13	482
Marta Briarava Italy	8	294 0.8×	78 0.5×	93 0.7×	122 1.0×	111 1.1×	10	486
Giulia Rovesti Italy	11	162 0.4×	39 0.2×	50 0.4×	123 1.0×	59 0.6×	27	393
Carolina Ortiz Spain	9	218 0.6×	36 0.2×	74 0.6×	158 1.3×	45 0.5×	27	433
Erin Powell Canada	11	329 0.9×	50 0.3×	106 0.8×	148 1.2×	133 1.3×	26	543
Elisa Tassinari Italy	8	217 0.6×	36 0.2×	205 1.6×	145 1.2×	84 0.8×	34	457
Sara A. Väyrynen Finland	11	233 0.6×	56 0.3×	56 0.4×	93 0.8×	49 0.5×	17	408

Countries citing papers authored by Claire Gallois

Since Specialization

Citations

This map shows the geographic impact of Claire Gallois's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claire Gallois with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claire Gallois more than expected).

Fields of papers citing papers by Claire Gallois

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claire Gallois. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claire Gallois. The network helps show where Claire Gallois may publish in the future.

Co-authorship network of co-authors of Claire Gallois

This figure shows the co-authorship network connecting the top 25 collaborators of Claire Gallois. A scholar is included among the top collaborators of Claire Gallois based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claire Gallois. Claire Gallois is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Garinet, Simon, et al.. (2025). Molecular features and clinical actionability of gene fusions in colorectal cancer. Critical Reviews in Oncology/Hematology. 208. 104656–104656. 1 indexed citations

Taı̈eb, Julien, et al.. (2024). Early-Onset colorectal Cancer: From the laboratory to the clinic. Cancer Treatment Reviews. 130. 102821–102821. 11 indexed citations

Pilati, Camilla, Claire Gallois, Hélène Blons, et al.. (2024). ERBB2 Comprehensive Profiling and Prognostication in Stage III Colon Cancer: Findings From PETACC8 and IDEA-France Cohorts. Gastroenterology. 168(4). 714–724.e4. 1 indexed citations

Grégory, Jules, Frédéric Bert, Anna Pellat, et al.. (2024). Diagnosis and treatment of bacterial peritonitis in patients with gastrointestinal cancer: an observational multicenter study. Therapeutic Advances in Medical Oncology. 16. 12703176–12703176.

Ambrosini, Margherita, David Tougeron, Dominik Paul Modest, et al.. (2024). BRAF + EGFR +/- MEK inhibitors after immune checkpoint inhibitors in BRAF V600E mutated and deficient mismatch repair or microsatellite instability high metastatic colorectal cancer. European Journal of Cancer. 210. 114290–114290. 7 indexed citations

Palmieri, Lola‐Jade, Émilie Soularue, Chloé Broudin, et al.. (2023). Chemotherapy-induced ileitis associated or not with colitis in digestive oncology patients: An AGEO multicentre study. Digestive and Liver Disease. 55(10). 1426–1433. 1 indexed citations

Gallois, Claire, Julien Taı̈eb, Sara Lonardi, et al.. (2023). Transcriptomic signatures of MSI-high metastatic colorectal cancer to predict efficacy of immune checkpoint inhibitors.. Journal of Clinical Oncology. 41(16_suppl). 3570–3570. 3 indexed citations

Gallois, Claire, Thierry André, Sophie Mouillet‐Richard, et al.. (2023). Predictive models of recurrence from transcriptomic signatures of the tumor microenvironment and cell cycle in stage III colon cancer from PETACC-8 and IDEA France trials.. Journal of Clinical Oncology. 41(16_suppl). 3523–3523.

Gallois, Claire, Édouard Auclin, Elisabeth Bergen, et al.. (2023). 625P Efficacy and safety of the combination of encorafenib and cetuximab in patients with BRAF V600E mutated metastatic colorectal cancer: An AGEO real-world multicentre study. Annals of Oncology. 34. S446–S446. 4 indexed citations

10.

Wasan, Harpreet, Sara Lonardi, Jayesh Desai, et al.. (2023). P-386 Novel data visualization and unsupervised machine learning techniques to support optimal management of toxicity profiles of encorafenib plus cetuximab in patients with BRAFV600E-mutant metastatic colorectal cancer. Annals of Oncology. 34. S148–S149. 1 indexed citations

11.

Pernot, Simon, Olivier Pellerin, Laurent Mineur, et al.. (2022). Phase III randomized trial comparing systemic versus intra-arterial oxaliplatin, combined with LV5FU2 +/- irinotecan and a targeted therapy, in the first-line treatment of metastatic colorectal cancer restricted to the liver (OSCAR): PRODIGE 49. Digestive and Liver Disease. 54(3). 324–330. 6 indexed citations

12.

Taı̈eb, Julien, Sara Lonardi, Jayesh Desai, et al.. (2022). Adverse Events Associated with Encorafenib Plus Cetuximab in Patients with BRAFV600E-mutant Metastatic Colorectal Cancer: An in-depth Analysis of the BEACON CRC Study. Clinical Colorectal Cancer. 22(1). 59–66. 9 indexed citations

13.

Meyer, Antoine, David Malka, Margarida Matias, et al.. (2021). Local treatment of pancreatic cancer metastases: A multicenter French study of the AGEO group. Clinics and Research in Hepatology and Gastroenterology. 45(6). 101607–101607. 4 indexed citations

14.

Basile, Debora, Claire Gallois, Fabio Puglisi, et al.. (2021). Practices and expectations on the use of circulating tumor DNA in colorectal cancer patients: A bi-national AGEO/AIOM/GERCOR/FFCD/FRENCH survey. Clinics and Research in Hepatology and Gastroenterology. 45(3). 101681–101681. 4 indexed citations

15.

Basile, Debora, Claire Gallois, Fabio Puglisi, et al.. (2020). 484P Practices and expectations on the use of circulating tumor DNA in colorectal cancer patients: A bi-national AGEO/AIOM/GERCOR/FFCD/FRENCH survey. Annals of Oncology. 31. S446–S446. 1 indexed citations

16.

Taı̈eb, Julien & Claire Gallois. (2020). Adjuvant Chemotherapy for Stage III Colon Cancer. Cancers. 12(9). 2679–2679. 61 indexed citations

17.

Gallois, Claire, Pascal Artru, Astrid Lièvre, et al.. (2019). Evaluation of two nutritional scores' association with systemic treatment toxicity and survival in metastatic colorectal cancer: an AGEO prospective multicentre study. European Journal of Cancer. 119. 35–43. 28 indexed citations

18.

Gallois, Claire, Julien Taı̈eb, Delphine Le Corre, et al.. (2018). Prognostic Value of Methylator Phenotype in Stage III Colon Cancer Treated with Oxaliplatin-based Adjuvant Chemotherapy. Clinical Cancer Research. 24(19). 4745–4753. 24 indexed citations

19.

Gallois, Claire, Julien Taı̈eb, Delphine Le Corre, et al.. (2017). Prognostic value of methylator phenotype in stage III colon cancer treated with oxaliplatin-based adjuvant chemotherapy. Annals of Oncology. 28. v161–v161. 7 indexed citations

20.

Gallois, Claire, Pierre Laurent‐Puig, & Julien Taı̈eb. (2015). Methylator phenotype in colorectal cancer: A prognostic factor or not?. Critical Reviews in Oncology/Hematology. 99. 74–80. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact